Published in Archives

The latest industry updates to know — Weekly Glance

This is editorially independent content
1 min read

For your contact lens wearers ...

You have a new lens to prescribe.

Johnson & Johnson Vision Care launched Acuvue Oasys Max 1-Day Multifocal contact lenses for presbyopia in both spherical and multifocal options. This lens has two unique features:

TearStable Technology, designed to maximize tear film stability and lock in moisture for all day comfort.

An OptiBlue light filter, which has the highest level blue-violet filter in the industry at 60% to reduce light scatter. (via)

For your patients with Stargardt disease ...

Clinical trials are happening. Nanoscope Therapeutics announced completion of enrollment in its STARLIGHT phase 2 clinical trial. The company is using optogenetic gene therapy to treat Stargardt disease.

Read more about optogenetics here.

For your patients with AMD risk factors ...

Heru announced the expansion of its wearable health and wellness platform with the launch of dark adaption. (via)

For your patients with dry eye …

TearLab has changed its name to Trukera Medical and unveiled the first product, ScoutPro Osmolarity System, under the new company name.